Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00468871
Status:
COMPLETED
Last Update Posted:
2011-12-08
First Post:
2007-05-02
Brief Title:
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy
Sponsor:
Bausch Lomb Incorporated
Organization:
Bausch Lomb Incorporated
Study Overview
Official Title:
A Multicenter Randomized Controlled Study to Evaluate the Safety and Efficacy of an Intravitreal Fluocinolone Acetonide 05mg Implant Compared to Standardized Therapy in Subjects With Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status:
COMPLETED
Status Verified Date:
2011-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a 3 yearsuperiority multicenter open-label randomised controlled safety and efficacy study The aim of this study is to evaluate the effect of an intravitreal fluocinolone acetonide 059 mg implant compared to standardized therapy in subjects with unilateral or bilateral non-infectious uveitis affecting the posterior segment of the eye
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None